Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative intravenous calcitriol for inflammation after percutaneous nephrolithotomy
IRCT20230815059154N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of calcitriol in nephrolithiasis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Serum inflammatory factors. Started Aug 2023; status: completed.
02
Drugs
calcitriol
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT20230815059154N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230815059154N1.